Injective vs Midnight — how do they compare? Injective trades at Rp92,698 (market cap Rp9,26T, Rp1,75T 24h volume), while Midnight trades at Rp528.05 (market cap Rp8,75T, Rp282,87M 24h volume). The key difference: Injective and Midnight are close in size by market cap, and Midnight's supply is capped (16,6B / 24B NIGHT (70%)) while Injective's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Injective for 36 Days and Midnight for 9 Days on average.
| INJ | NIGHT | |
|---|---|---|
Market Cap | Rp9,26T | Rp8,75T |
Volume (24h) | Rp1,75T | Rp282,87M |
Circulating Supply | 100M INJ | 16,6B / 24B NIGHT (70%) |
Typical Hold Time | 36 Days | 9 Days |
Signals from Pluang's Aura AI — not financial advice
Injective (INJ) is trading at Rp92,221 with a market cap of Rp9.18T, showing a bullish technical signal overall. The moving averages are strongly bullish, while oscillators are neutral. Key resistance lies at Rp93,589 and support at Rp86,188. The asset has a hold time of 36 days, indicating moderate holding behavior. No major protocol updates or ecosystem news are noted recently, but the token remains active in decentralized exchange and DeFi sectors.
Overall outlook is cautiously optimistic due to bullish technicals, but risks include high volatility and neutral oscillators suggesting potential consolidation. Opportunities lie in continued ecosystem growth, while major risks involve crypto market sentiment shifts and regulatory uncertainties. Investors should monitor key resistance levels for breakout signals.
NIGHT is currently trading at Rp526.13 with a market cap of Rp8.75T, showing bearish technical signals with moving averages indicating strong selling pressure. The token trades near its pivot point with key support at Rp508 and resistance at Rp539. With 70% of max supply in circulation and average hold time of 9 days, the asset shows moderate network activity amid current market conditions.
Overall outlook remains cautious with technical indicators favoring sellers, though neutral oscillators suggest potential consolidation. Key opportunities include RSI_6 buy signal at oversold levels, while major risks involve bearish momentum continuation and limited fundamental catalysts. Investors should monitor support levels closely for potential entry points.
What Pluang investors did over the last 30 days
Latest headlines on both assets
Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.
Read more on INJ →Midnight is a next-generation blockchain developed by Charles Hoskinson, co-founder of Ethereum and founder of Cardano. It uses zero-knowledge proofs to enable applications that protect user, commercial, and transaction data without sacrificing utility. Midnight introduces a public–private dual-state architecture and a dual-component token model designed to balance privacy, selective disclosure, and on-chain functionality.
Read more on NIGHT →